Category Archives: News

Cellulac acquires Aer Sustainable Energy (Aer-Bio)

10 fold saving in enzymes, 4 fold increase in algae oils within 2 hours reducing the process costs of Omega-3, animal feed and biofuels Dublin, Ireland, 18th May 2015: Cellulac, the industrial biochemicals company, today announces the acquisition of Aer Sustainable Energy Limited, also known as Aer-Bio, effective 18th May...
Read more Comments are closed

5 year, €35m Pharmafilter partnership with Cellulac

Partnership delivers 2nd generation bioplastics supply chain solution for hospitals Dundalk, Ireland and Amsterdam, The Netherlands, 30th March 2015: Cellulac, the industrial biochemicals company, and Pharmafilter, a provider of integrated waste management infrastructure for dealing with complex waste, are delighted to announce a commercial partnership to deliver the first vertically...
Read more Comments are closed

Lactic acid from lactose whey in world first continuous production runs

Cambridge, UK. 19 May 2014: Cellulac, the industrial biochemicals company is delighted to announce the world’s first ever industrial level continuous production of lactic acid from deproteinized lactose whey. Our 10 day production run concluded this week and delivered optically pure D(-) Lactic Acid suitable for conversion to bioplastics. Whey...
Read more Comments are closed

Cellulac to acquire patent portfolio and industrial biochemical equipment from Pursuit Dynamics PLC

Cellulac Limited, the industrial biochemicals company, announces the acquisition of Pursuit Marine Drive Limited, a subsidiary of Pursuit Dynamics PLC, subject to shareholder approval. The acquisition includes certain intellectual property rights, test equipment and commercial installations of industrial biochemical equipment in a number of US ethanol production plants. A separate...
Read more Comments are closed

Consortium of Irish Biomedical companies in €3m joint venture to deliver biodegradable implants from 2nd generation biochemicals.

Three Irish biomedical companies  Cellulac Limited Venn Life Sciences Holdings Plc (“Venn”) (AIM: VENN) Bipharmed West Limited today are pleased to announce a joint venture to pursue the development of biodegradable human implants. This consortium brings together complementary expertise and skills that are essential to commercialise this programme: Cellulac Limited...
Read more Comments are closed